These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2584142)

  • 21. Antiplatelet activities of FK409, a new spontaneous NO releaser.
    Kita Y; Hirasawa Y; Yoshida K; Maeda K
    Br J Pharmacol; 1994 Oct; 113(2):385-8. PubMed ID: 7834188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SNF4435C and D, novel immunosuppressants produced by a strain of Streptomyces spectabilis. II. Structure elucidation.
    Takahashi K; Tsuda E; Kurosawa K
    J Antibiot (Tokyo); 2001 Jul; 54(7):548-53. PubMed ID: 11560372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver.
    Ohmori H; Dhar DK; Nakashima Y; Hashimoto M; Masumura S; Nagasue N
    Transplantation; 1998 Sep; 66(5):579-85. PubMed ID: 9753335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats.
    Matsumura Y; Nishiura M; Deguchi S; Hashimoto N; Ogawa T; Seo R
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1084-91. PubMed ID: 9864296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics.
    Hatanaka H; Kino T; Miyata S; Inamura N; Kuroda A; Goto T; Tanaka H; Okuhara M
    J Antibiot (Tokyo); 1988 Nov; 41(11):1592-601. PubMed ID: 2461926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours.
    Zhang JM; Orihashi K; Sueda T; Matsuura Y
    Ann Thorac Surg; 2000 Nov; 70(5):1601-6. PubMed ID: 11093494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent.
    Hirasawa Y; Sugimoto T; Fukuyama S; Kato Y; Takamatu H; Ohno M; Nishino S; Kato M; Maeda K; Seki J; Kita Y
    Eur J Pharmacol; 1996 May; 303(1-2):55-9. PubMed ID: 8804911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vitro pulmonary vascular effects of FK409 (nitric oxide donor): a study in normotensive and pulmonary hypertensive rats.
    Wanstall JC; Kaye JA; Gambino A
    Br J Pharmacol; 1997 May; 121(2):280-6. PubMed ID: 9154338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SNF4435C and D, novel immunosuppressants produced by a strain of Streptomyces spectabilis. I. Taxonomy, fermentation, isolation and biological activities.
    Kurosawa K; Takahashi K; Tsuda E
    J Antibiot (Tokyo); 2001 Jul; 54(7):541-7. PubMed ID: 11560371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. gamma-Chloronorvaline, a leucine analog from Streptomyces.
    Narayanan S; Iyengar MR; Ganju PL; Rengaraju S; Shomura T; Tsuruoka T; Inouye S; Niida T
    J Antibiot (Tokyo); 1980 Nov; 33(11):1249-55. PubMed ID: 6894746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of antiplatelet effects of two nitric oxide-donating agents, FR146801 and FK409.
    Hirasawa Y; Kato Y; Fukuyama S; Ohno M; Nishino S; Kato M; Kita Y
    Thromb Haemost; 1998 Mar; 79(3):620-4. PubMed ID: 9531052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new cytotoxic 2H-pyran compound produced by acid treatment of the fermentation broth of Streptomyces sp.
    Nosaka C; Kunimoto S; Masuda T; Ohsono M; Iinuma H; Tsuchida T; Hamada M; Takeuchi T
    Biol Pharm Bull; 1999 May; 22(5):546-8. PubMed ID: 10375181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of canine warm ischemic small bowel injury by novel combination of nitric oxide donor, FK409, and cytokine suppressive anti-inflammatory agent FR167653.
    Totsuka E; Murata A; Nishimura A; Umehara M; Nara M; Ono H; Nozaki T; Takiguchi M; Wajima N; Takahashi K; Seino K; Narumi S; Hakamada K; Sasaki M
    Transplant Proc; 2004 Sep; 36(7):1988-90. PubMed ID: 15518720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effects of new generation fungal derived nitric oxide donors on rabbit basilar artery.
    Islam MS; Ohkuma H; Kimura M; Suzuki S
    Neurol Med Chir (Tokyo); 2003 Apr; 43(4):175-80; discussion 180. PubMed ID: 12760495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A80915, a new antibiotic complex produced by Streptomyces aculeolatus. Discovery, taxonomy, fermentation, isolation, characterization, and antibacterial evaluation.
    Fukuda DS; Mynderse JS; Baker PJ; Berry DM; Boeck LD; Yao RC; Mertz FP; Nakatsukasa WM; Mabe J; Ott J
    J Antibiot (Tokyo); 1990 Jun; 43(6):623-33. PubMed ID: 1696251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Close correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level.
    Kita Y; Sugimoto T; Hirasawa Y; Yoshida K; Maeda K
    Br J Pharmacol; 1994 Sep; 113(1):5-6. PubMed ID: 7812632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimetabolites produced by microorganisms. XIII. The synthesis and microbiological production of a novel amino acid, L-2-amino-4-(2-aminoethoxy) butanoic acid.
    Scannell JP; Pruess DL; Ax HA; Jacoby A; Kellett M; Stempel A
    J Antibiot (Tokyo); 1976 Jan; 29(1):38-43. PubMed ID: 931793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphostin (LK6-A), a novel immunosuppressant from Streptomyces sp. KY11783: taxonomy of the producing organism, fermentation, isolation and biological activities.
    Nagata H; Ochiai K; Aotani Y; Ando K; Yoshida M; Takahashi I; Tamaoki T
    J Antibiot (Tokyo); 1997 Jul; 50(7):537-42. PubMed ID: 9711243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fattiviracin A1, a novel antiherpetic agent produced by Streptomyces microflavus Strain No. 2445. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation.
    Uyeda M; Yokomizo K; Miyamoto Y; Habib EE
    J Antibiot (Tokyo); 1998 Sep; 51(9):823-8. PubMed ID: 9820232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pH shift and precursor feeding strategy in a low-toxicity FR-008/candicidin derivative CS103 fermentation bioprocess by a mutant of Streptomyces sp. FR-008.
    Mao X; Wang F; Zhang J; Chen S; Deng Z; Shen Y; Wei D
    Appl Biochem Biotechnol; 2009 Dec; 159(3):673-86. PubMed ID: 19148776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.